InvestorsHub Logo

All-Bidness

07/04/20 4:48 PM

#90778 RE: T Stark #90776

How would they be in phase 3?

Humanigen announces data on the first clinical use of lenzilumab, the proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor, in 12 COVID-19 patients.


Amatuer17

07/04/20 6:02 PM

#90786 RE: T Stark #90776

Your wuestion is very valid. For some reason (politics) despite having more eIND, Lero needs more and larger trials.